Displaying drugs 26 - 50 of 1616 in total
PF-04217903
PF-04217903 has been used in trials studying the treatment of Neoplasms.
Investigational
Matched Name: … PF-04217903 …
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
Matched Description: … PF-04217903 has been used in trials studying the treatment of Neoplasms. …
PF-03382792
Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers).
Investigational
Matched Name: … PF-03382792 …
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
Matched Description: … Pf 03382792 is under investigation in clinical trial NCT01045863 (To Evaluate Safety, Tolerability, Plasma …
PF-03814735
PF-03814735 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Name: … PF-03814735 …
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
Matched Description: … PF-03814735 has been used in trials studying the treatment of Solid Tumors. …
PF-06459988
PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer).
Investigational
Matched Name: … PF-06459988 …
Matched Description: … PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal …
Matched Description: … PF-06459988 is under investigation in clinical trial NCT02297425 (A Study For Patients With EGFRm (Epidermal …
PF-04620110
PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).
Investigational
Matched Name: … PF-04620110 …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 …
Matched Description: … PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 …
PF-04634817
PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).
Investigational
Matched Name: … PF-04634817 …
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
Matched Description: … Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects). ... PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine …
PF-06700841
PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers).
Investigational
Matched Name: … PF-06700841 …
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
Matched Description: … PF-06700841 in Japanese Healthy Volunteers). ... PF-06700841 is under investigation in clinical trial NCT03236493 (Safety and Pharmacokinetic Study of …
PF-05105679
PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).
Investigational
Matched Name: … PF-05105679 …
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
Matched Description: … Volunteers Study Of PF-05105679). ... PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy …
PF-05212377
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
Investigational
Matched Name: … PF-05212377 …
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
Matched Description: … PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy ... of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms …
EF-022
EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.
Investigational
Matched Synonyms: … EF 022 …
Matched Name: … EF-022 …
Matched Description: … EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic …
Matched Name: … EF-022 …
Matched Description: … EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic …
MDX-018
MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD)...
Investigational
Matched Name: … MDX-018 …
Matched Description: … MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin- …
Matched Description: … MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin- …
AIT-034
AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal studies to enhance memory and to reverse memory deficits in severely impaired animals that do not respond to Neotrofin. AIT-034 does not induce the production of NGF, and its mechanism of action is therefore...
Investigational
Matched Name: … AIT-034 …
Matched Description: … AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal ... AIT-034 does not induce the production of NGF, and its mechanism of action is therefore believed to be ... There is some evidence that AIT-034 could complement Neotrofin as a treatment for Alzheimer's disease …
Matched Description: … AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal ... AIT-034 does not induce the production of NGF, and its mechanism of action is therefore believed to be ... There is some evidence that AIT-034 could complement Neotrofin as a treatment for Alzheimer's disease …
MK-0249
MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
Investigational
Matched Name: … MK-0249 …
OSI-027
OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.
Investigational
Matched Name: … OSI-027 …
Matched Description: … OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma. …
Matched Description: … OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma. …
AKN-028
AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Matched Name: … AKN-028 …
Matched Description: … AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia. …
Matched Description: … AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia. …
MGD-024
MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.
Investigational
Matched Name: … MGD-024 …
Matched Description: … MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule. …
Matched Description: … MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule. …
ENB-003
ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.
Investigational
Matched Synonyms: … ENB 003 …
Matched Name: … ENB-003 …
Matched Description: … ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for …
Matched Name: … ENB-003 …
Matched Description: … ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for …
MK-0482
MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Investigational
Matched Name: … MK-0482 …
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …
KF-0210
KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.
Investigational
Matched Name: … KF-0210 …
Matched Description: … KF-0210 is a small molecule developed by Keythera Pharmaceuticals. …
Matched Description: … KF-0210 is a small molecule developed by Keythera Pharmaceuticals. …
Displaying drugs 26 - 50 of 1616 in total